Silvercrest Asset Management Group LLC Artivion, Inc. Transaction History
Silvercrest Asset Management Group LLC
- $13.6 Billion
- Q1 2025
A detailed history of Silvercrest Asset Management Group LLC transactions in Artivion, Inc. stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 481,241 shares of AORT stock, worth $14 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
481,241Holding current value
$14 Million% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding AORT
# of Institutions
188Shares Held
38.7MCall Options Held
19.5KPut Options Held
2.5K-
Black Rock Inc. New York, NY6.64MShares$194 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.9MShares$84.7 Million0.09% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$81.5 Million2.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.78MShares$81.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.26MShares$65.9 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.18B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...